Keywords: Actelion, Firs-quarter 2012 financial results

Actelion 1st-qtr profits slump as lead product sales slip

Article | 19 April 2012

Switzerland-based Actelion (ATLN: VX), Europe’s largest biotech firm, posted first-quarter 2012 financial results this morning, showing that product sales ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Actelion

Go to company listing